Pediatric and young adult leukemia adoptive therapy (PLAT)-08: A phase 1 study of SC-DARIC33 in pediatric and young adults with relapsed or refractory CD33+ AML. Background: Myelodysplastic ...

Results from a retrospective study compared and explored biomarkers associated with outcomes in myelodysplastic syndrome (MDS) with plasma cell neoplasms. MDS is a group of heterogeneous clonal ...

Please provide your email address to receive an email when new articles are posted on . Nearly one-third of patients received a reclassified diagnosis. Seven percent of misdiagnosed patients received ...

Evidence suggests as many as 29% of people with myeloproliferative neoplasms (MPN) or myelodysplastic syndrome (MDS)/MPN have chronic kidney disease. Renal complications are not considered a classical ...

Presession focused on MDS/MPN-related anemia. Participants can register for the presession and SOHO 2025 at soho.click/2025 . Through dynamic case studies, interactive polling, and interdisciplinary ...